Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Preclinical Probes for Oncology

  • You have access
    In vitro investigation of 225Ac-PSMA I&T and its decay products on PSMA expressing cancer cells
    Alexander Wurzer, Samaa Saleh, Susanne Kossatz, Christof Seidl, Matthias Eiber, Kerstin Hürkamp, Wei Bo Li, Alfred Morgenstern, Frank Bruchertseifer, Calogero D'Alessandria and Wolfgang Weber
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2354;
  • You have access
    Development of pH-responsive fatty acid-based albumin-binding ligands for cancer targeted imaging
    Jeong-Seob Lee, SANGHEE LEE, Wooseung Lee, Miyeon Jeon, Jee-eun Hwang, Byung Chul Lee and Hyung-Jun Im
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2456;
  • You have access
    Developing a new 18F-labeled peptide for PET imaging of GPC3 expression in hepatocellular carcinoma
    Quan Chen, Xiaoyun Zhou, Juno Van Valkenburgh, Peter Conti and Kai Chen
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2459;
  • You have access
    Radiochemistry, biodistribution and imaging study of 161Tb and 155Tb labeled crown-αMSH for MC1R targeting theranostics
    Luke Wharton, Scott McNeil, Gokce Engudar, Chengcheng Zhang, Michiel Van de Voorde, Maarten Ooms, Peter Kunz, Francois Benard, Valery Radchenko and Hua Yang
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2356;
  • You have access
    PET imaging of a modified anti-PD-L1 probe 68Ga-BMS-986192 in immunocompetent mice and non-human primates
    Huimin Zhou and Xiaohua Zhu
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2306;
  • You have access
    124I-Labeled Antibody Fragments for Non-invasive Evaluation of Tumour PD-L1 expression In Vivo
    Yuan Cheng, Dai Shi, Zhan Xu, Zhan Si, Qingyu Lin, Fu Zhequan, Hongcheng Shi and Dengfeng Cheng
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2452;
  • You have access
    GPC3-targeted ImmunoPET Imaging of Hepatocellular Carcinomas
    Shuxian An, Jianjun Liu and Weijun Wei
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2479;
  • You have access
    Synthesis and evaluation of novel 68Ga-labeled bombesin analogs for imaging gastrin-releasing peptide receptor expression with positron emission tomography
    Lei Wang, Zhengxing Zhang, Helen Merkens, Nadine Colpo, Jutta Zeisler, Chengcheng Zhang, Aron Roxin, Ruiyan Tan, Shreya Bendre, Francois Benard and Kuo-Shyan Lin
    Journal of Nuclear Medicine August 1, 2022, 63 (supplement 2) 2453;
  • You have access
    A Peptide Heterodimer Tracer Targeting CXCR4 and Integrin αvβ3 for Pancreatic Cancer Imaging
    Yaqun Jiang, Yu Long, Yongxue Zhang, Xiaoli Lan and Yongkang Gai
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1498;
  • You have access
    Preclinical ImmunoPET Imaging of Gastric cancer-Infiltrating Myeloid Cells Using Zirconium-89 Labeled Anti-CD11b Antibody
    Yingying Zhang and Dengfeng Cheng
    Journal of Nuclear Medicine May 1, 2021, 62 (supplement 1) 1512;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
SNMMI

© 2025 SNMMI

Powered by HighWire